{"id":"W2945798005","doi":"10.1016/j.trci.2019.04.001","title":"Enrichment factors for clinical trials in mild‐to‐moderate Alzheimer's disease","year":2019,"lang":"en","type":"article","venue":"Alzheimer s & Dementia Translational Research & Clinical Interventions","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Allergan; Genentech; Grifols; H. Lundbeck A/S; University of Oxford; Sunovion; National Institute of General Medical Sciences; Teva Pharmaceutical Industries; Biogen; American College of Radiology; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Acadia University; Cognoptix; Pfizer; AbbVie; Merck; Alzheimer's Association","keywords":"Clinical trial; Disease; Alzheimer's disease; Medicine; Internal medicine; Gerontology; Oncology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.04375596,0.000404687,0.001523297,0.00101647,0.000294305,0.0001987581,0.0005427092,0.0002841111,0.005493449],"category_scores_gemma":[0.007516215,0.0003497249,0.003322697,0.0009164185,0.000390201,0.0003627928,0.0002259027,0.001381259,0.0009008006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000410112,"about_ca_system_score_gemma":0.0009515304,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006725886,"about_ca_topic_score_gemma":0.000123311,"domain_scores_codex":[0.9847825,0.005464443,0.004850731,0.001453513,0.002150307,0.001298537],"domain_scores_gemma":[0.9800034,0.01570138,0.0003457846,0.000788102,0.001485817,0.001675479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006003853,0.006529411,0.9188178,0.0001101274,0.01030498,0.00002390134,0.00008735509,0.00002263467,0.00006758385,0.002670712,0.00957119,0.04579047],"study_design_scores_gemma":[0.009367797,0.002947313,0.951381,0.000673009,0.004982725,0.000001034732,0.0001743477,0.001594949,0.0002487889,0.003461968,0.02479682,0.0003702151],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9112217,0.02843094,0.01154497,0.02418986,0.001769197,0.0195511,0.0007341076,0.000129287,0.002428855],"genre_scores_gemma":[0.9928029,0.0007114505,0.002446669,0.0006627095,0.0004242522,0.001361056,0.00093809,0.00007302697,0.0005798061],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08158126,"threshold_uncertainty_score":0.9998955,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6245633221272933,"score_gpt":0.6228928141282654,"score_spread":0.001670507999027904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}